Peer Reviewed Study on China Biopharma; New Advances in Biopharmaceutical Technology in China, 2nd ed.
December 13, 2018
Just released: Advances in Biopharmaceutical Technology in China, 2nd ed. is a peer-reviewed, ready reference for all aspects of biopharmaceuticals in China, including an understanding of the China biopharma current situation, and future opportunities. This is a must-read analysis of the state of biopharma in China.
The volume is published by BioPlan Associates, Inc., in cooperation with the Society for Industrial Microbiology and Biotechnology (SIMB). It provides a comprehensive overview of the biopharmaceutical industry, and the state of technology in China.
This reference’s 1,100+ pages of data-rich analysis and comprehensive assessment of China’s state-of-the-industry provides trends and analysis on the industry. It covers all types of organizations involved in biopharma in China, domestic, multinational, and government.